This section of the web-site contains information on medicines, advertising of which is not foreseen by the legislation. Information in this section is intended for reference only, has exclusively scientific and informative character and should not be treated as advertising information for a wide range of people. According to the current legislation, access to this information is granted to medical and pharmaceutical employees. Please confirm that you are a medical or pharmaceutical employee.


As statistics shows, runny nose (rhinitis) is the most common symptom of colds, while sinusitis is the most common complication of a cold. Cinnabsin - a natural German combined medication can help to cope with it and prevent complications.

It’s been for 50 years since Cinnabsin has been used to treat rhinitis and sinusitis. Its composition is chosen so that to help the nose to cope with an illness. The main feature of Cinnabsin is its diverse action profile. Cinnabsin not only safely recovers nasal breathing by removing swelling of nose mucous and paranasal sinuses, but also thins thick mucus, makes its expectoration easier, thereby normalizing natural mechanism of cleansing nasal mucosa and paranasal sinuses. Another Cinnabsin advantage is its ability to raise body defenses, which accelerates recovery and prevents transition of acute into chronic process. Cinnabsin is approved for use in children from 2 and adults.

Cinnabsin* due to its diverse action profile stands out of vasoconstrictor drops, which only restore nasal breathing, thereby causing vasoconstriction of blood-vessels and impairing the natural mechanism of nasal mucosa cleansing.

Cinnabsin – applicable in runny nose and sinusitis!

Cinnabsin tablets: produced by DHU Arzneimittel GmbH & Co. KG (Germany), Marketing Authorization No. UA/6790/01/01 dd. 14.12.12.

*Drug advertising. Read instructions carefully and consult a doctor before use. Keep out of the reach of children.

Self-medication can be harmful to your health



Ask a question

To prevent automated spam submissions leave this field empty.